CTNNBIP1 and lung carcinoma: The results showed that lower levels of CTNNBIP1 were associated with an overall poorer prognosis and a reduced relapse-free survival when 204 lung cancer patients from the GSE31210 project were analyzed (p = 0.011 and p = 0.002, respectively; Figure S1).